Each month our editorial team sifts through hundreds of papers and curates notable findings—for practitioners and informed readers who want to stay current with the evidence. Subscribe to the monthly Research Digest for expert analysis and concise summaries of key papers.
3 papers
Ketamine has been used as a safe anesthetic for more than 50 years and also works well for pain relief. The active form is S(+)-ketamine and it is mainly broken down into an active metabolite called norketamine. Ketamine blocks NMDA receptors in the brain, which helps explain its special effects…
In 14 people with opioid use disorder who each received a single 10 mg/kg dose of ibogaine, researchers measured blood levels of ibogaine and its metabolites over 24 hours and linked those levels to side effects. They found large differences between people in how fast ibogaine was cleared, and that…
This review says that low (sub-anesthetic) doses of ketamine can produce strong short-term pain relief by blocking NMDA receptors and by boosting descending pain-inhibiting pathways. It is well documented to help with pain around the time of surgery and is linked to less long-term postoperative pain and lower opioid use.…
